Advances in Urology / 2017 / Article / Tab 4

Clinical Study

The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Table 4

Changes of mean uroflowmetric parameters in patients who continued the silodosin treatment ().

Parameters0 mos.3 mos.6 mos.12 mos.18 mos.24 mos.30 mos.36 mos.42 mos.48 mos.

(ml)181.7196.6206.8209.1215.3204.1218.7197.4220.6209.2
(SD)(98.1)(93.5)(127.0)(139.9)(162.3)(108.9)(132.8)(95.8)(110.3)(127.1)
(ml/s)11.712.413.013.113.213.012.912.712.712.9
(SD)(3.6)(4.6)(6.1)(5.8)(6.5)(4.3)(5.7)(5.8)(4.4)(6.5)
(ml/s)6.16.67.28.07.87.8
(SD)(2.3)(3.0)(3.5)(3.8)(3.5)(2.2)(2.9)(3.1)(2.3)(3.1)
PVR (ml)60.442.647.246.358.154.262.678.763.372.4
(SD)(70.2)(44.0)(38.9)(38.2)(48.8)(42.3)(49.0)(75.6)(34.7)(41.5)

, , and versus baseline, the paired Student’s -test with Bonferroni correction.